These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16773633)
1. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. Wiley A; Katsaros D; Chen H; Rigault de la Longrais IA; Beeghly A; Puopolo M; Singal R; Zhang Y; Amoako A; Zelterman D; Yu H Cancer; 2006 Jul; 107(2):299-308. PubMed ID: 16773633 [TBL] [Abstract][Full Text] [Related]
2. [Hypermethylation of hMLH1 and microsatellite instability in ovarian mucinous tumors]. Chen HZ; Ye DF; Xie X; Hu M; Lu WG Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):457-61. PubMed ID: 12974095 [TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
4. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Strathdee G; Appleton K; Illand M; Millan DW; Sargent J; Paul J; Brown R Am J Pathol; 2001 Mar; 158(3):1121-7. PubMed ID: 11238060 [TBL] [Abstract][Full Text] [Related]
5. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas. Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754 [TBL] [Abstract][Full Text] [Related]
6. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633 [TBL] [Abstract][Full Text] [Related]
8. The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients. Gifford G; Paul J; Vasey PA; Kaye SB; Brown R Clin Cancer Res; 2004 Jul; 10(13):4420-6. PubMed ID: 15240532 [TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients. Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364 [TBL] [Abstract][Full Text] [Related]
10. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927 [TBL] [Abstract][Full Text] [Related]
11. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Leung WK; To KF; Man EP; Chan MW; Bai AH; Hui AJ; Chan FK; Sung JJ Am J Gastroenterol; 2005 Oct; 100(10):2274-9. PubMed ID: 16181380 [TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma. Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447 [TBL] [Abstract][Full Text] [Related]
14. [Promoter methylation profile in breast cancer]. Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763 [TBL] [Abstract][Full Text] [Related]
15. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Waki T; Tamura G; Sato M; Motoyama T Oncogene; 2003 Jun; 22(26):4128-33. PubMed ID: 12821947 [TBL] [Abstract][Full Text] [Related]
16. Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC). Chaudhry P; Srinivasan R; Patel FD Cancer Invest; 2009 Oct; 27(8):877-84. PubMed ID: 19548140 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. An C; Choi IS; Yao JC; Worah S; Xie K; Mansfield PF; Ajani JA; Rashid A; Hamilton SR; Wu TT Clin Cancer Res; 2005 Jan; 11(2 Pt 1):656-63. PubMed ID: 15701853 [TBL] [Abstract][Full Text] [Related]
18. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. Kim H; Kim YH; Kim SE; Kim NG; Noh SH; Kim H J Pathol; 2003 May; 200(1):23-31. PubMed ID: 12692837 [TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer. Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745 [TBL] [Abstract][Full Text] [Related]
20. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia. Lenz G; Hutter G; Hiddemann W; Dreyling M Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]